Found 226 matching trials
Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD PHASE2 Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Show More Location
Hospital Maissoneuve
Learn More & Join Trial
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Show More Location
Knight Cancer Institute at Oregon Health and Science University
Learn More & Join Trial
Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse PHASE2 The objective of the study is the evaluation of efficacy and safety of obin...
Show More Location
Centrum Onkologii - Instytut im. Marii Skłodowskiej- Curie Klinika Nowotworów Układu Chłonnego
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study PHASE1 The goal of this study is to evaluate the safety of melphalan and autologou...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation PHASE1 This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Show More Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Learn More & Join Trial
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia PHASE1 Background:
Sickle cell disease (SCD) is an inherited disorder of the bloo...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 PHASE2 This is a Phase II multi-center trial single arm trial of autologous transp...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Vinorelbine and Gemcitabine in Myeloma PHASE2 The purpose of this study is to determine whether the efficacy of gemcitabi...
Show More Location
Department for Medical Oncology; University Hospital/Inselspital
Learn More & Join Trial
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL PHASE2 Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Show More Location
Stanford University Medical Center
Learn More & Join Trial